Because of AKT-induced inhibition of PGC-1α leads to inhibition of fatty acid oxidation in the liver, promoting PGC-1α activity in insulin-resistant hepatocytes may be able to eliminate lipid imbalance in T2DM patients [34]. The gene discussed is PPARGC1A; the disease is type 2 diabetes mellitus.